Cargando…

Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy

Diabetes is a major contributor to the increasing burden of heart failure prevalence globally, at least in part due to a disease process termed diabetic cardiomyopathy. Diabetic cardiomyopathy is characterised by cardiac structural changes that are caused by chronic exposure to the diabetic milieu....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tate, Mitchel, Perera, Nimna, Prakoso, Darnel, Willis, Andrew M., Deo, Minh, Oseghale, Osezua, Qian, Hongwei, Donner, Daniel G, Kiriazis, Helen, De Blasio, Miles J., Gregorevic, Paul, Ritchie, Rebecca H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532155/ https://www.ncbi.nlm.nih.gov/pubmed/34690762 http://dx.doi.org/10.3389/fphar.2021.719290

Ejemplares similares

Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
por: Parker, Alex M., et al.
Publicado: (2021)

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2019)

Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
por: Prakoso, Darnel, et al.
Publicado: (2021)

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes
por: De Blasio, Miles J., et al.
Publicado: (2020)

Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy
por: Cohen, Charles D., et al.
Publicado: (2023)

The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart
por: Tate, Mitchel, et al.
Publicado: (2019)

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2021)

Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition
por: Cohen, Charles D., et al.
Publicado: (2021)

Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
por: Qin, Cheng Xue, et al.
Publicado: (2017)

Author Correction: Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
por: Qin, Cheng Xue, et al.
Publicado: (2018)

Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac(2-26), Against Myocardial Infarction
por: Qin, Cheng Xue, et al.
Publicado: (2019)

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019)

Therapeutic Targeting of Endosome and Mitochondrial Reactive Oxygen Species Protects Mice From Influenza Virus Morbidity
por: To, Eunice E., et al.
Publicado: (2022)

Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges
por: Bernardo, Bianca C., et al.
Publicado: (2018)

Insights into bone morphogenetic proteins in cardiovascular diseases
por: Ye, Di, et al.
Publicado: (2023)

Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis
por: Core, Amanda B., et al.
Publicado: (2014)

Beyond osteogenesis: an in vitro comparison of the potentials of six bone morphogenetic proteins
por: Rivera, Jessica C., et al.
Publicado: (2013)

Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection
por: Harpur, Christopher M, et al.
Publicado: (2023)

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice
por: Sun, Qin-Juan, et al.
Publicado: (2021)

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice
por: Vollaire, Julien, et al.
Publicado: (2019)

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2017)

In Vitro and In Vivo Osteogenesis Induced by Icariin and Bone Morphogenetic Protein-2: A Dynamic Observation
por: Xie, Lina, et al.
Publicado: (2020)

Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering
por: Zhang, Xin, et al.
Publicado: (2019)

A Process for the Design and Development of Novel Bone Morphogenetic Protein-7 (BMP-7) Mimetics With an Example: THR-184
por: Carlson, William D., et al.
Publicado: (2022)

Influenza Virus Infection during Pregnancy as a Trigger of Acute and Chronic Complications
por: Oseghale, Osezua, et al.
Publicado: (2022)

Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart
por: Horlock, Duncan, et al.
Publicado: (2021)

The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
por: Winbanks, Catherine E., et al.
Publicado: (2013)

Emerging roles of microRNAs in septic cardiomyopathy
por: Wu, Mingyan, et al.
Publicado: (2023)

Micellized Protein Transduction Domain-Bone Morphogenetic Protein-7 Efficiently Blocks Renal Fibrosis Via Inhibition of Transforming Growth Factor-Beta–Mediated Epithelial–Mesenchymal Transition
por: Kim, Seonghun, et al.
Publicado: (2020)

Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy
por: Chen, Yun, et al.
Publicado: (2020)

Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress
por: Lin, Huan, et al.
Publicado: (2020)

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
por: Sun, Huiyan, et al.
Publicado: (2023)

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
por: Wu, Meng, et al.
Publicado: (2018)

Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy
por: Sasagawa, Shota, et al.
Publicado: (2016)

Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
por: Bernardo, Bianca C., et al.
Publicado: (2014)

Feto-Maternal Trafficking of Exosomes in Murine Pregnancy Models
por: Sheller-Miller, Samantha, et al.
Publicado: (2016)

The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy
por: Yue-Chun, Li, et al.
Publicado: (2016)

CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy
por: Veitch, Christopher R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rh8pr2vuh243ko563ge8alc5ra